Pricing Log in Create free account

QIAGEN N.V. (QGEN) vs Revvity Inc. (RVTY)

QIAGEN N.V. and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $16.8B against $10.5B — 1.6× the size. QIAGEN N.V. trades at the lower P/E: 26.1× against 71.9×. Revvity Inc. grew revenue faster over the last twelve months: 4.56% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 8.61%) and the higher return on invested capital (6.62% vs 2.50%). Both pay a dividend; QIAGEN N.V. yields more (0.69% vs 0.19%). Across the 23 metrics below, QIAGEN N.V. leads on 20 and Revvity Inc. on 3.

Valuation

Metric QGEN RVTY Diagnostics & Research median
P/E 26.07 71.89 34.52
P/S 5.00 5.73 4.24
P/B 3.13 2.33 3.42
Price to free cash flow 23.83 28.19 33.51
EV/EBITDA 17.43 25.08 23.44
EV/Sales 5.40 6.61 5.18
Earnings yield 3.84% 1.39% (1.50%)
Free cash flow yield 4.20% 3.55% 0.00%

Profitability

Metric QGEN RVTY Diagnostics & Research median
Gross margin 62.20% 55.91% 48.32%
Operating margin 21.21% 12.65% (5.68%)
Net margin 19.49% 8.61% (4.10%)
Free cash flow margin 20.98% 20.48% 0.00%
Return on equity 11.93% 0.00% 0.00%
Return on assets 6.99% 2.14% (6.05%)
Return on invested capital 6.62% 2.50% 0.00%

Growth

Metric QGEN RVTY Diagnostics & Research median
Revenue growth (TTM) 2.96% 4.56% 8.99%
EPS growth (last fiscal year) 424.32% (5.91%) 20.36%
Revenue growth, 5-year CAGR 2.25% 1.41% 7.30%
Net income growth, 5-year CAGR 3.42% (19.82%) 0.00%

Health

Metric QGEN RVTY Diagnostics & Research median
Debt to equity 0.49 0.36 0.01
Current ratio 2.85 2.65 2.27
Net debt to EBITDA 0.84 3.00 0.68

Dividend

Metric QGEN RVTY Diagnostics & Research median
Dividend yield 0.69% 0.19% 0.67%
Payout ratio 0.18 0.12 0.20

Size

Metric QGEN RVTY Diagnostics & Research median
Market cap 10.50b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack